Hyperbaric oxygen therapy does not improve the effects of standardized treatment in a severe attack of ulcerative colitis: A prospective randomized study

Scandinavian Journal of Gastroenterology

Volumn 48, Issue 9, 2013, Pages 1033-1040

  Pagoldh, Maria ^a   Hultgren, Elin ^a   Arnell, Per ^a   Eriksson, Anders ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Complementary therapies; Hyperbaric oxygenation therapy; Inflammatory bowel diseases; Ulcerative colitis

Indexed keywords

ADOLESCENT; ARTICLE; CLINICAL ASSESSMENT TOOL; COLON RESECTION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FETUS WEIGHT; HUMAN; HYPERBARIC OXYGEN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MAYO SCORE; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETAMETHASONE; COLECTOMY; COLITIS, ULCERATIVE; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERBARIC OXYGENATION; MALE; MESALAMINE; PREDNISOLONE; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT FAILURE;

EID: 84882967910     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.819443     Document Type: Article

References (30)

1. Bernklev T, Jahnsen J, Lygren I, Henriksen M, Vatn M, Moum B. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: Psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis 2005;11: 909-18 (Pubitemid 41428850)
2. Hjortswang H, Ström M, Almer S. Health-related quality of life in Swedish patients with ulcerative colitis. Am J Gastroenterol 1998;93:2203-11 (Pubitemid 29076875)
3. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-94 (Pubitemid 351173057)
4. Shih DQ, Targan SR. Immunopathogenesis of inflammatory bowel disease. World J Gastroenterol 2008;14:390-400 (Pubitemid 351320847)
5. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008;8:458-66 (Pubitemid 351733422)
6. Kucharzik T, Maaser C, Lügering A, Kagnoff M, Mayer L, Targan S, et al. Recent understanding of IBD pathogenesis: Implications for future therapies. Inflamm Bowel Dis 2006; 12:1068-83
7. Ibrahim CB, Aroniadis C, Brandt LJ. On the role of ischemia in the pathogenesis of IBD: A review. Inflamm Bowel Dis 2010;16:696-702
8. Hudson M, Chitolie A, Hutton RA, Smith MS, Pounder R E,Wakefield A J. Thrombotic vascular risk factors in inflammatory bowel disease. Gut 1996;38:733-7 (Pubitemid 26167482)
9. Tsuchiya M, Miura S, Asakura H, Hibi T, Tanaka T, Aiso S, et al. Angiographic evaluation of vascular changes in ulcerative colitis. Angiology 1980;31:147-53 (Pubitemid 10101659)
10. Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, et al. Cyclosporine versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: A parallel, open-label randomised controlled trial. Lancet 2012;380:1909-15
11. Andersson P, Söderholm JD. Surgery in ulcerative colitis: Indication and timing. Dig Dis 2009;27:335-40
12. Hanson B, MacDonald R, Shaukat A. Endoscopic and medical therapy for chronic radiation proctopathy: A systematic review. Dis Colon Rectum 2012;55:1081-95
13. Mendenhall WM, McKibben BT, Happe BS, Nichols RC, Henderson RH, Mendenhall NP. Management of radiation proctitis. Am J Clin Oncol 2012; Epub ahead of print
14. Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med 1996;334:1642-8 (Pubitemid 126613652)
15. Lavy A, Weisz G, Adir Y, Ramon Y, Melamed Y, Eidelman S. Hyperbaric oxygen for perianal Crohn's disease. J Clin Gastroenterol 1994;19:202-5 (Pubitemid 24302034)
16. Brady CE 3rd, Cooley BJ, Davis JC. Healing of severe perineal and cutaneous Crohn's disease with hyperbaric oxygen. Gastroenterology 1989;97:756-60 (Pubitemid 19205151)
17. Nelson EW Jr, Bright DE, Villar LF. Closure of refractory perineal Crohn's lesion. Integration of hyperbaric oxygen into case management. Dig Dis Sci 1990;35:1561-5
18. Colombel JF, Mathieu D, Bouault JM, Lesage X, Zavadil P, Quandalle P, et al. Hyperbaric oxygenation in severe perineal Crohn's disease. Dis Colon Rectum 1995;38:609-14
19. Rachmilewitz D, Karmeli F, Okon E, Rubenstein I, Better OS. Hyperbaric oxygen: A novel modality to ameliorate experimental colitis. Gut 1998;43:512-18 (Pubitemid 28462037)
20. Buchman AL, Fife C, Torres C, Smith L, Aristizibal J. Hyperbaric oxygen therapy for severe ulcerative colitis. J Clin Gastroenterol 2001;33:337-9 (Pubitemid 32880978)
21. Demirturk L, Ozel M, Yazgan Y, Buchman AL. Therapeutic efficacy of hyperbaric oxygenation in ulcerative colitis refractory to medical treatment. J Clin Gastroenterol 2002; 35:286-7
22. Gürbüz AK, Elbüken E, Yazgan Y, Yildiz S. A different therapeutic approach in patients with severe ulcerative colitis: Hyperbaric oxygen treatment. South Med J 2003;96:632-3 (Pubitemid 38281731)
23. Karkumov M, Nikolov N, Georgiev L, Mitreva D, Uzunova A. Hyperbaric oxygenation as a part of the treatment of chronic ulcerohemorrhagic colitis. Vutr Boles 1991; 30:78-80
24. Kuroki K, Masuda A, Uehara H, Kuroki A. A new treatment for toxic megacolon. Lancet 1998;352:782 (Pubitemid 28404561)
25. Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995;36:718-23
26. Weisz G, Lavy A, Adir Y, Melamed Y, Rubin D, Eidelman S, et al. Modification of in vivo and in vitro TNF-Alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease. J Clin Immunol 1997;17: 154-9 (Pubitemid 27145739)
27. Ratzenhofer-Komenda B, Favory R, Welslau W, Smolle-Juttner FM, Mathieu D. Physiologic effects of Hyperbaric oxygen transport and tissue pressure. In Mathieu D, editors. Handbook on hyperbaric medicine. 1st edition. Dordrecht: Springer The Netherlands; 2006. pp 49-73
28. Rossignol DA. Hyperbaric oxygen treatment for inflammatory bowel disease: A systematic review and analysis. Med Gas Res 2012;2:6
29. Sullivan M, Karlsson J, Ware J. The Swedish SF-36 Health Survey-1. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995;41:1349-58
30. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989; 96:804-10 (Pubitemid 19057603)